We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Atrasentan Spermatogenesis and Testicular Function
Updated: 12/31/1969
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Decreasing the Incidence of Delirium After Cardiac Surgery
Updated: 12/31/1969
Decreasing the Incidence of Delirium After Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Decreasing the Incidence of Delirium After Cardiac Surgery
Updated: 12/31/1969
Decreasing the Incidence of Delirium After Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Updated: 12/31/1969
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated: 12/31/1969
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Updated: 12/31/1969
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Updated: 12/31/1969
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated: 12/31/1969
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Updated: 12/31/1969
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia Caregivers
Updated: 12/31/1969
Central Meditation and Imagery Therapy for Major Depressive Disorder in Family Dementia Caregivers
Status: Enrolling
Updated: 12/31/1969
Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia Caregivers
Updated: 12/31/1969
Central Meditation and Imagery Therapy for Major Depressive Disorder in Family Dementia Caregivers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Mobility Training Using Exoskeletons for Functional Recovery After Stroke
Updated: 12/31/1969
Effect of Mobility Training Using Robotic Exoskeletons on Functional Recovery in Individuals With Severe Stroke
Status: Enrolling
Updated: 12/31/1969
Mobility Training Using Exoskeletons for Functional Recovery After Stroke
Updated: 12/31/1969
Effect of Mobility Training Using Robotic Exoskeletons on Functional Recovery in Individuals With Severe Stroke
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Life Enhancing Activities for Family Caregivers
Updated: 12/31/1969
Life Enhancing Activities for Family Caregivers (LEAF)
Status: Enrolling
Updated: 12/31/1969
Life Enhancing Activities for Family Caregivers
Updated: 12/31/1969
Life Enhancing Activities for Family Caregivers (LEAF)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Updated: 12/31/1969
A Phase I/II Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Recurrent or Refractory Sarcomas Including Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of SPARC1103 in Subjects With Spasticity
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Study of SPARC1103 in Subjects With Spasticity
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Study of SPARC1103 in Subjects With Spasticity
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Study of SPARC1103 in Subjects With Spasticity
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Study of SPARC1103 in Subjects With Spasticity
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Study of SPARC1103 in Subjects With Spasticity
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials